The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up +0.61%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.72%. September E-mini...
The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.28%. September E-mini S&P futures (ESU25...
The S&P 500 Index ($SPX ) (SPY ) today is up +0.66%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.83%. September E-mini S&P futures (ESU25...
September S&P 500 E-Mini futures (ESU25) are trending up +0.16% this morning as investors look past U.S. President Donald Trump’s latest tariff threats and await the Federal Reserve’s June meeting...
Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, July 7th:Verona Pharma VRNA: This company which is focused on developing and commercializing innovative...
Apellis Pharmaceuticals’ APLS shares gained 3.2% on Tuesday following the announcement of a capped royalty deal with Sobi, under which Apellis will receive up to $300 million in return for 90% of its...
Verona Pharma (VRNA) is showing exceptional technical strength, hitting a new high in morning trading on June 24. The stock has a 100% technical “Buy” signal via Barchart. The stock has surged 515%...
Summary Verona Pharma (VRNA) shows strong technical indicators with a 54.89% gain since 11/19, driven by Barchart's Trend Seeker buy signal. The company focuses on developing ensifentrine for respiratory...
DAVID ZACCARDELLI, the President and CEO of $VRNA ($VRNA), sold 162,800 shares of the company on 12-06-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.1%...